In a small trial of 14 patients, a CRISPR gene editing therapy improved vision among 11 participants, according to research led by a Mass General Brigham clinician.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Gene therapy candidate restores vision in some patients
